 William Blair analystRaju Prasadmaintained aBuyrating on Logicbio Therapeutics LOGCResearch Report today. The companys shares closed last Monday at 4.06, close to its 52-week low of 3.05.According toTipRanks.com, Prasad is a 1-star a 